BIOBASE & MEDICA 2025 Has Successfully Concluded!
From November 17 to 20, BIOBASE showcased its full portfolio of laboratory instruments, medical devices, and IVD solutions at MEDICA 2025 in Düsseldorf. With a strong product lineup and a professional presentation, BIOBASE once again captured global attention.
During the exhibition, customers from around the world visited the booth and held in-depth discussions with BIOBASE representatives on areas such as in vitro diagnostics, biosafety, low-temperature storage, and biochemical analysis. They spoke highly of BIOBASE’s technical capabilities, product quality, and continuous innovation.
Among the many exhibits, the automatic urine analyzer BH-QNY01 became the focus of attention at the exhibition with its core advantages of intelligent operation, high throughput, and exceptional convenience. With a 10.1-inch touch screen, automated sample handling, a 600-strip chamber, and closed puncture analysis, the BH-QNY01 delivers a safer, smarter, and more efficient urinalysis experience.
BIOBASE maintains its commitment to innovation, continuously expanding its product ecosystem—from biosafety equipment to automated diagnostic platforms. This integrated development provides flexible, efficient, and comprehensive solutions for various professional applications.
We sincerely thank all visitors and partners for their trust and collaboration. The end of MEDICA marks a new beginning — BIOBASE will continue working with global partners to build a smarter and healthier world.